Clinical Trials and Research

Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment

In 2025, Tiger BioSciences supported and generated five peer-reviewed retrospective clinical studies, two of which focused on the company's flagship product, completeFT...

2025 Biological Device Application Approvals. How FDA Clearances Are Reshaping Blood Banking, Diagnostics, and Point of Care Medicine

From blood bank software and immunohematology analysers, to HIV diagnostics and platelet rich plasma systems, the 2025 approval landscape signals a clear shift towards automation, safety, traceability, and point of care innovation across transfusion and laboratory medicine...

Galaxy Therapeutics Completes Enrollment in Pivotal SEAL IT IDE Trial

The WNBA subgroup builds upon the prior WEB-IT trial framework and extends the indication to a broader size range...

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Ginkgo plans to apply its cell and enzyme engineering expertise to support development of these new diagnostic tools...

RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit

The Accuro 3S Needle Guide Kit, designed for use with the Accuro 3S ultrasound imaging system and Dual-Array transducer, includes single-use, sterile components that support infection control and promote workflow efficiency...

Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection

First-of-its-kind research offers participants exclusive access to combined oral and gut microbiome testing...

UniSA Scientists Develop AI Tool to Map Gene Interactions Fueling Tumour Growth

The researchers showed that the AI-driven system not only detects well-known cancer genes but also uncovers previously hidden ones...

CathVision announces appointment of Eric Thepaut as Independent Chairman and Releases ECGenius System Version 3.5

This release introduces hardware and software enhancements designed to improve workflow efficiency and system performance...

CG Oncology Reports Promising New Data for Cretostimogene in NMIBC at SUO 2025

Robust clinical pipeline that spans multiple late-stage studies across intermediate- and high-risk NMIBC...

Alpha Tau Receives FDA Approval to Initiate Trial for Patients with Locally Recurrent Prostate Cancer

FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent prostate cancer...